Jun 15, 2021
Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is collaborating with psychedelic therapy educational platform Fluence to provide design and training for the psychotherapeutic portion of its Phase 2a clinical trials for treating eating disorders and fibromyalgia. “Fluence is led by researchers and psychotherapists with direct experience in conducting psychedelic clinical trials and is the foremost provider of psychotherapeutic training for health professionals that are administering psychedelic compounds to patients,” reads a recent article. The piece quotes Tryp President and Chief Science Officer Jim Gilligan as saying, “In the fast-moving arena of psychedelic therapies, Fluence has established themselves as the leader in psychotherapy design and training. Psychotherapy is an essential component of the effective administration of our innovative psilocybin formulations for the chronic pain and eating disorder indications that we are pursuing. Fluence’s experience with training hundreds of clinicians combined with the training protocol they are creating with Tryp will help create a safer and more effective treatment protocol for our clinical trials and ultimately for patients suffering from these conditions.”
To view the full article, visit https://ibn.fm/oM9jn
About Tryp Therapeutics Inc.
Tryp Therapeutics is a pharmaceutical company focused on developing compounds with known activity and safety profiles for the treatment of rare and other diseases with unmet medical needs. Tryp’s psilocybin-for-neuropsychiatric disorders (“PFN”) program is focused on the development of synthetic psilocybin as a new class of drug for the treatment of certain neuropsychiatric-based disorders. Tryp’s lead PFN drug candidate is TRP-8802 for the treatment of fibromyalgia, a chronic pain syndrome estimated to affect more than five million people in the United States. In addition to its PFN program, Tryp is developing TRP-1001, an oral formulation of razoxane for the treatment of soft-tissue sarcoma. Soft-tissue sarcomas are a rare and diverse group of tumors that account for about 1% of all cancers in adults and 7% in children. Based on the prevalence of soft-tissue sarcomas in the United States, Tryp believes it is a rare disease and that TRP-1001 should qualify for orphan drug status. For more information about the company, please visit www.TrypTherapeutics.com.
NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]
PsychedelicNewsWire is part of the InvestorBrandNetwork.
Defense Secretary Gilberto “Gibo” Teodoro slammed the apparent threat from the Chinese envoy to the Philippines, saying his department is currently studying the statement.
TACLOBAN CITY — Northern Samar mourned the death of Raul Daza, a political titan who served the province as governor and congressman for decades, with local leaders honoring his legacy of public service, democratic principles, and contributions to the province’s development. Daza, 91, died on Monday, Oct. 12, after a lingering illness, his family announced
The Department of Interior and Local Government (DILG) has revealed the Mindanao politician tagged in the attempted smuggling of shabu from Laos to the Philippines: former Bangsamoro Parliament member Edrieza Rimbang. But who is Rimbang?
MANILA, Philippines — President Ferdinand Marcos Jr. on Friday vowed to strengthen the Philippine Coast Guard’s (PCG) capabilities and readiness amid increasingly complex maritime challenges, as he urged its personnel to remain steadfast in their service. Marcos made the commitment during the PCG’s 125th founding anniversary celebration at South Harbor in Manila. “And so as
TACLOBAN CITY — The barangay chairman of Libtong-Dako in Naval, Biliran, was shot dead in the early hours of Friday after he went with his younger brother to confront a man who allegedly had been throwing stones at their residence, police said. The victim, identified as Junrey Ancero, 48, was found lying on the ground
COTABATO CITY— Bangsamoro Interim Chief Minister Abdulraof Macacua on Thursday welcomed President Ferdinand Marcos Jr.’s affirmation of Bangsamoro autonomy, including its democratic institutions and political processes. “This principled position powerfully affirms the autonomy rightfully earned through decades of struggle, sacrifice, and unwavering commitment to peace,” Macacua said in a statement after the President congratulated the
The Senate Finance Committee approved Friday the proposed budget of the Department of Education (DepEd) for fiscal year 2027, subject to the discussion and submission of requested documents.
MANILA, Philippines — The camp of Vice President Sara Duterte on Friday accused the Marcos administration of using the National Bureau of Investigation (NBI) to persecute her politically, calling the bureau’s findings on her alleged misdeclared properties a “shameless smear campaign.” Duterte’s spokesperson, Salvador Paolo Panelo Jr., questioned NBI Director Melvin Matibag’s decision to publicize
The Ayala chairman wants an 'honest conversation' on Philppine investments and talks teamwork to a roomful of rivals at Makati Business Club's sapphire anniversary
The Senate Electoral Tribunal (SET) on Friday denied the motion for reconsideration for the dismissal of the quo warranto petition seeking the removal of Senator Erwin Tulfo from office due to his supposed citizenship issues.
LEGAZPI CITY — Two jail facilities in Camarines Norte will install water treatment facilities under a government partnership to improve access to safe drinking water for persons deprived of liberty (PDLs) and jail personnel. The three-year Project Aqua will provide a water treatment system, a drinking water station, and a backup generator for the Labo
Senate President Sherwin Gatchalian on Friday accepted the apology of House lead prosecutor Representative Gerville Luistro of Batangas for the wacky photos taken by the prosecution panel inside the session hall, but maintained that a warning will still be issued against them.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.